Skip to main content
# Title Department Research Member Research Year
161 Effect of Ketamine Instillation on Acute and Chronic Post Mastectomy Pain, a Dose Finding Clinical Study Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2022
162 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Hanaan Ahmed Mohammed Ahmed 2022
163 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Rania Mohamed Abd-Elemam 2022
164 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Department of Clinical Pathology Dr. Noha gaber sayed 2022
165 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Marwa Tammam Ameen Hammam 2022
166 Could Argyrophilic Nucleolar Organizer Regions count mirror DNA Ploidy in Malignant Salivary Gland Tumors? Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2022
167 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2022
168 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2022
169 Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim Cohort Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2022
170 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022